132 related articles for article (PubMed ID: 14972466)
1. Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging.
Hubbard JS; Rohrmann S; Landis PK; Metter EJ; Muller DC; Andres R; Carter HB; Platz EA
Urology; 2004 Feb; 63(2):253-8. PubMed ID: 14972466
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic plasma vitamin C levels and the subsequent risk of prostate cancer.
Berndt SI; Carter HB; Landis PK; Hallfrisch J; Rohrmann S; Metter EJ; Platz EA
Nutrition; 2005 Jun; 21(6):686-90. PubMed ID: 15925292
[TBL] [Abstract][Full Text] [Related]
3. Glycemic status and risk of prostate cancer.
Darbinian JA; Ferrara AM; Van Den Eeden SK; Quesenberry CP; Fireman B; Habel LA
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):628-35. PubMed ID: 18349280
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
[TBL] [Abstract][Full Text] [Related]
5. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.
Dahle SE; Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Hsing AW
J Urol; 2002 Aug; 168(2):599-604. PubMed ID: 12131317
[TBL] [Abstract][Full Text] [Related]
6. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.
Gong Z; Neuhouser ML; Goodman PJ; Albanes D; Chi C; Hsing AW; Lippman SM; Platz EA; Pollak MN; Thompson IM; Kristal AR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1977-83. PubMed ID: 17035408
[TBL] [Abstract][Full Text] [Related]
7. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
8. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
9. Body size and composition and prostate cancer risk.
MacInnis RJ; English DR; Gertig DM; Hopper JL; Giles GG
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1417-21. PubMed ID: 14693731
[TBL] [Abstract][Full Text] [Related]
10. Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese.
Thomas GN; Ho SY; Lam KS; Janus ED; Hedley AJ; Lam TH;
Obes Res; 2004 Nov; 12(11):1805-13. PubMed ID: 15601976
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
Goff DC; D'Agostino RB; Haffner SM; Otvos JD
Metabolism; 2005 Feb; 54(2):264-70. PubMed ID: 15690322
[TBL] [Abstract][Full Text] [Related]
12. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men--a 3.6-year prospective study.
Hadaegh F; Zabetian A; Harati H; Azizi F
Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):310-5. PubMed ID: 16868890
[TBL] [Abstract][Full Text] [Related]
13. Statin drugs and risk of advanced prostate cancer.
Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
[TBL] [Abstract][Full Text] [Related]
14. Anthropometrics and prostate cancer risk.
Littman AJ; White E; Kristal AR
Am J Epidemiol; 2007 Jun; 165(11):1271-9. PubMed ID: 17395597
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years.
Lund Håheim L; Wisløff TF; Holme I; Nafstad P
Am J Epidemiol; 2006 Oct; 164(8):769-74. PubMed ID: 16952929
[TBL] [Abstract][Full Text] [Related]
16. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation.
Hu G; Lindström J; Valle TT; Eriksson JG; Jousilahti P; Silventoinen K; Qiao Q; Tuomilehto J
Arch Intern Med; 2004 Apr; 164(8):892-6. PubMed ID: 15111376
[TBL] [Abstract][Full Text] [Related]
17. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.
Hammarsten J; Högstedt B
Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer mortality and factors related to the insulin resistance syndrome.
Colangelo LA; Gapstur SM; Gann PH; Dyer AR; Liu K
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):385-91. PubMed ID: 11927499
[TBL] [Abstract][Full Text] [Related]
19. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of hyperglycemia and cancer risk.
Stattin P; Björ O; Ferrari P; Lukanova A; Lenner P; Lindahl B; Hallmans G; Kaaks R
Diabetes Care; 2007 Mar; 30(3):561-7. PubMed ID: 17327321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
